These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 16444921

  • 1. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C, Cosentino E, De Sanctis D.
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [Abstract] [Full Text] [Related]

  • 2. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A, Teo KK.
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [Abstract] [Full Text] [Related]

  • 3. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors.
    Juggi JS, Koenig-Berard E, Van Gilst WH.
    Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
    Ceconi C, Mastrorilli F, Squasi PA, Gaitani S, Guardigli G, Ferrari R.
    Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
    [Abstract] [Full Text] [Related]

  • 5. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S.
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
    [Abstract] [Full Text] [Related]

  • 6. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
    Modesti PA, Vanni S, Gensini GF.
    Ital Heart J Suppl; 2003 Aug; 4(8):623-34. PubMed ID: 14655458
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evolution of angiotensin-converting enzyme inhibitors.
    Wyvratt MJ.
    Clin Physiol Biochem; 1988 Aug; 6(3-4):217-29. PubMed ID: 2849521
    [Abstract] [Full Text] [Related]

  • 10. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G, Vecchio C.
    G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
    [Abstract] [Full Text] [Related]

  • 11. Congestive heart failure: new therapeutic strategies.
    Pitt B.
    Clin Cardiol; 1992 Sep; 15 Suppl 1():I2-4. PubMed ID: 1395211
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
    Healey JS, Morillo CA, Connolly SJ.
    Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
    [Abstract] [Full Text] [Related]

  • 14. Comparing angiotensin-converting enzyme inhibitor trial results in patients with acute myocardial infarction.
    Cody RJ.
    Arch Intern Med; 1994 Sep 26; 154(18):2029-36. PubMed ID: 8092908
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A, Pedrinelli R, Arzilli F, Abdel-Haq B, Magagna A, Lucarini A, Graziadei L, Nuccorini A, Taddei S.
    Int J Clin Pharmacol Res; 1985 Sep 26; 5(6):429-38. PubMed ID: 3005182
    [Abstract] [Full Text] [Related]

  • 16. Renin-angiotensin system modulation: the weight of evidence.
    Brown B, Hall AS.
    Am J Hypertens; 2005 Sep 26; 18(9 Pt 2):127S-133S. PubMed ID: 16125049
    [Abstract] [Full Text] [Related]

  • 17. [Prevention with angiotensin-converting enzyme (ACE) inhibitors].
    Ertl G, Gaudron P, Neubauer S, Bauer B.
    Z Kardiol; 1992 Sep 26; 81 Suppl 4():205-10. PubMed ID: 1290300
    [Abstract] [Full Text] [Related]

  • 18. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M, Solomon SD.
    Curr Opin Cardiol; 2006 Jul 26; 21(4):268-72. PubMed ID: 16755193
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin converting enzyme inhibition in cardiovascular risk populations: a practical approach to identify the patient who will benefit most.
    Asselbergs FW, van Gilst WH.
    Curr Opin Cardiol; 2007 Jul 26; 22(4):267-72. PubMed ID: 17556876
    [Abstract] [Full Text] [Related]

  • 20. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M, Gohlke P, Paul M, Stoll M, Unger T.
    J Cardiovasc Pharmacol; 1994 Jul 26; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.